These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32040747)

  • 1. Mixed methods analysis of Health-Related Quality of Life in ambulant individuals affected with RYR1-related myopathies pre-post-N-acetylcysteine therapy.
    Capella-Peris C; Cosgrove MM; Chrismer IC; Emile-Backer M; Razaqyar MS; Elliott JS; Kuo A; Wakim PG; Meilleur KG
    Qual Life Res; 2020 Jun; 29(6):1641-1653. PubMed ID: 32040747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding Symptoms in RYR1-Related Myopathies: A Mixed-Methods Analysis Based on Participants' Experience.
    Capella-Peris C; Cosgrove MM; Chrismer IC; Razaqyar MS; Elliott JS; Kuo A; Emile-Backer M; Meilleur KG
    Patient; 2020 Aug; 13(4):423-434. PubMed ID: 32329019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6-minute walk test as a measure of disease progression and fatigability in a cohort of individuals with RYR1-related myopathies.
    Witherspoon JW; Vasavada RP; Waite MR; Shelton M; Chrismer IC; Wakim PG; Jain MS; Bönnemann CG; Meilleur KG
    Orphanet J Rare Dis; 2018 Jul; 13(1):105. PubMed ID: 29970108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized controlled trial of
    Todd JJ; Lawal TA; Witherspoon JW; Chrismer IC; Razaqyar MS; Punjabi M; Elliott JS; Tounkara F; Kuo A; Shelton MO; Allen C; Cosgrove MM; Linton M; Michael D; Jain MS; Waite M; Drinkard B; Wakim PG; Dowling JJ; Bönnemann CG; Emile-Backer M; Meilleur KG
    Neurology; 2020 Mar; 94(13):e1434-e1444. PubMed ID: 31941795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliability and Validity of Self-Report Questionnaires as Indicators of Fatigue in RYR1-Related Disorders.
    Kuo A; Todd JJ; Witherspoon JW; Lawal TA; Elliott J; Chrismer IC; Shelton MO; Razaqyar MS; Jain MS; Vasavada R; Waite M; Drinkard B; Michael D; Richarte A; Bönnemann CG; Meilleur KG
    J Neuromuscul Dis; 2019; 6(1):133-141. PubMed ID: 30714968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional impairments, fatigue and quality of life in RYR1-related myopathies: A questionnaire study.
    van Ruitenbeek E; Custers JAE; Verhaak C; Snoeck M; Erasmus CE; Kamsteeg EJ; Schouten MI; Coleman C; Treves S; Van Engelen BG; Jungbluth H; Voermans NC
    Neuromuscul Disord; 2019 Jan; 29(1):30-38. PubMed ID: 30578099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress and successful antioxidant treatment in models of RYR1-related myopathy.
    Dowling JJ; Arbogast S; Hur J; Nelson DD; McEvoy A; Waugh T; Marty I; Lunardi J; Brooks SV; Kuwada JY; Ferreiro A
    Brain; 2012 Apr; 135(Pt 4):1115-27. PubMed ID: 22418739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular calcium leak as a therapeutic target for RYR1-related myopathies.
    Kushnir A; Todd JJ; Witherspoon JW; Yuan Q; Reiken S; Lin H; Munce RH; Wajsberg B; Melville Z; Clarke OB; Wedderburn-Pugh K; Wronska A; Razaqyar MS; Chrismer IC; Shelton MO; Mankodi A; Grunseich C; Tarnopolsky MA; Tanji K; Hirano M; Riazi S; Kraeva N; Voermans NC; Gruber A; Allen C; Meilleur KG; Marks AR
    Acta Neuropathol; 2020 Jun; 139(6):1089-1104. PubMed ID: 32236737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Fatigue Index as a Measure of Local Muscle Fatigability in Ryanodine Receptor Isoform-1-Related Myopathies.
    Witherspoon JW; Rekant JS; Wakim PG; Vasavada R; Waite M; Chrismer I; Shelton MO; Jain MS; Meilleur KG
    Front Neurol; 2019; 10():1234. PubMed ID: 31920904
    [No Abstract]   [Full Text] [Related]  

  • 11. Rycal S48168 (ARM210) for
    Todd JJ; Lawal TA; Chrismer IC; Kokkinis A; Grunseich C; Jain MS; Waite MR; Biancavilla V; Pocock S; Brooks K; Mendoza CJ; Norato G; Cheung K; Riekhof W; Varma P; Colina-Prisco C; Emile-Backer M; Meilleur KG; Marks AR; Webb Y; Marcantonio EE; Foley AR; Bönnemann CG; Mohassel P
    EClinicalMedicine; 2024 Feb; 68():102433. PubMed ID: 38318125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of drug modifiers for RYR1-related myopathy using a multi-species discovery pipeline.
    Volpatti JR; Endo Y; Knox J; Groom L; Brennan S; Noche R; Zuercher WJ; Roy P; Dirksen RT; Dowling JJ
    Elife; 2020 Mar; 9():. PubMed ID: 32223895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical model systems of ryanodine receptor 1-related myopathies and malignant hyperthermia: a comprehensive scoping review of works published 1990-2019.
    Lawal TA; Wires ES; Terry NL; Dowling JJ; Todd JJ
    Orphanet J Rare Dis; 2020 May; 15(1):113. PubMed ID: 32381029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychological treatments for people with epilepsy.
    Michaelis R; Tang V; Wagner JL; Modi AC; LaFrance WC; Goldstein LH; Lundgren T; Reuber M
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012081. PubMed ID: 29078005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of ER/SR resident proteins as biomarkers for ER/SR calcium depletion in skeletal muscle cells.
    Greer LK; Meilleur KG; Harvey BK; Wires ES
    Orphanet J Rare Dis; 2022 Jun; 17(1):225. PubMed ID: 35698232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ryanodine receptor 1-related disorders: an historical perspective and proposal for a unified nomenclature.
    Lawal TA; Todd JJ; Witherspoon JW; Bönnemann CG; Dowling JJ; Hamilton SL; Meilleur KG; Dirksen RT
    Skelet Muscle; 2020 Nov; 10(1):32. PubMed ID: 33190635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapies for RYR1-Related Myopathies: Where We Stand and the Perspectives.
    Beaufils M; Travard L; Rendu J; Marty I
    Curr Pharm Des; 2022; 28(1):15-25. PubMed ID: 34514983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-Related Quality of Life Components in Children With Neonatal Brachial Plexus Palsy: A Qualitative Study.
    Chang KW; Austin A; Yeaman J; Phillips L; Kratz A; Yang LJ; Carlozzi NE
    PM R; 2017 Apr; 9(4):383-391. PubMed ID: 27519824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of health-related quality of life in patients with systemic lupus erythematosus using PROMIS and Neuro-QoL.
    Lai JS; Beaumont JL; Jensen SE; Kaiser K; Van Brunt DL; Kao AH; Chen SY
    Clin Rheumatol; 2017 Mar; 36(3):555-562. PubMed ID: 27848056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.